Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.
about
Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Low free and bioavailable test ...... a prospective, clinical trial.
@en
type
label
Low free and bioavailable test ...... a prospective, clinical trial.
@en
prefLabel
Low free and bioavailable test ...... a prospective, clinical trial.
@en
P2093
P2860
P356
P1476
Low free and bioavailable test ...... a prospective, clinical trial.
@en
P2093
Ayşim Özağarı
Göksel Bayar
Hakan Şirin
Muammer Kendirci
Mustafa Aydın
Mustafa Kadıhasanoğlu
Orhan Tanrıverdi
P2860
P304
P356
10.5152/TUD.2017.35467
P577
2017-08-01T00:00:00Z